Antidepressants: A Branding Fail

We should have never named them antidepressants. It's not a medication fail so much as it is a branding fail that has led to widespread misunderstanding and miscommunication about the true nature and effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs). Selective Serotonin Reuptake Inhibitors (SSRIs), which are among the most commonly prescribed antidepressants, only demonstrate efficacy in about 30% of cases of depression on the first trial. This statistic understandably contributes to a significant level of frustration and disappointment among patients and healthcare providers alike.

White pills scattered across a blue background highlight the versatility of antidepressants, which are used for various medical conditions beyond depression.

The reality is that the term "antidepressants" can be misleading; while they may be the most frequently utilized, they are not necessarily the most effective class of medications available for treating depression. In fact, the antidepressants that have shown higher effectiveness rates, such as Monoamine Oxidase Inhibitors (MAOIs), are rarely prescribed in contemporary practice due to their complex side effect profiles and dietary restrictions. I haven’t had a patient take a MAOI in over 10 years. I have tried to prescribe a MAOI, but the patient was too scared to take it (completely understandable).

That said, labeling SSRIs as "antidepressants" fails to capture their broader applications. These medications are utilized to treat a variety of mental health conditions beyond just depression, including but not limited to Premenstrual Dysphoric Disorder (PMDD), anxiety disorders, Obsessive-Compulsive Disorder (OCD), Post-Traumatic Stress Disorder (PTSD), and more. This wide-ranging applicability suggests that the current nomenclature does not adequately reflect the multifaceted roles these medications play in mental health treatment.

Why aren’t they more effective across the board? The primary action of these medications is to increase levels of serotonin in the brain. However, it’s important to note that serotonin constitutes less than 5% of all neurotransmitters in your body. To consider serotonin as the sole or primary influencer of mood and emotional regulation is to overlook the complex interplay of various neurotransmitters and biological factors that contribute to mental health. Serotonin, while important, is not the heavy lifter in the context of mental well-being; she’s more like a Pilates queen—helping with stability and core strength but not necessarily driving the entire process. This limited focus on serotonin may explain why many individuals do not experience the relief they seek from these medications (and why SSRIs take so long to work for depression), highlighting the need for a more comprehensive understanding and approach to mental health treatment.